 Jeffrey Schowinsky
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 3 | 2018 | 743 | 1.040 |
Why?
| | Mycosis Fungoides | 2 | 2018 | 51 | 0.970 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2017 | 378 | 0.740 |
Why?
| | Lipomatosis | 1 | 2015 | 2 | 0.740 |
Why?
| | HMGA2 Protein | 1 | 2015 | 7 | 0.730 |
Why?
| | Adamantinoma | 1 | 2015 | 3 | 0.730 |
Why?
| | Synovial Membrane | 1 | 2015 | 56 | 0.710 |
Why?
| | Eosinophilia | 1 | 2015 | 121 | 0.670 |
Why?
| | Tibia | 1 | 2015 | 133 | 0.640 |
Why?
| | Skin Neoplasms | 2 | 2018 | 649 | 0.600 |
Why?
| | Lymphoma, T-Cell, Peripheral | 1 | 2012 | 9 | 0.590 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 76 | 0.540 |
Why?
| | Clonal Evolution | 2 | 2017 | 15 | 0.390 |
Why?
| | Biopsy, Needle | 1 | 2006 | 201 | 0.370 |
Why?
| | Rectum | 1 | 2006 | 131 | 0.360 |
Why?
| | Diagnostic Errors | 1 | 2006 | 140 | 0.360 |
Why?
| | Carrier Proteins | 2 | 2017 | 799 | 0.270 |
Why?
| | Keratins | 2 | 2015 | 188 | 0.260 |
Why?
| | Nuclear Proteins | 2 | 2017 | 653 | 0.260 |
Why?
| | Adenocarcinoma | 1 | 2006 | 716 | 0.250 |
Why?
| | Fatal Outcome | 2 | 2018 | 292 | 0.230 |
Why?
| | Fibromatosis, Aggressive | 1 | 2017 | 16 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 4 | 2016 | 2342 | 0.210 |
Why?
| | Tetrahydronaphthalenes | 1 | 2017 | 45 | 0.210 |
Why?
| | Leukemia, Neutrophilic, Chronic | 1 | 2017 | 5 | 0.210 |
Why?
| | Receptors, Colony-Stimulating Factor | 1 | 2017 | 9 | 0.210 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2017 | 65 | 0.210 |
Why?
| | Mediastinal Neoplasms | 1 | 2017 | 48 | 0.210 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 1039 | 0.200 |
Why?
| | Valine | 1 | 2017 | 89 | 0.200 |
Why?
| | Giant Cell Tumor of Bone | 1 | 2016 | 3 | 0.200 |
Why?
| | Mutation | 3 | 2017 | 2844 | 0.200 |
Why?
| | Skull Base Neoplasms | 1 | 2016 | 24 | 0.200 |
Why?
| | Lymphoma | 1 | 2017 | 176 | 0.190 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2017 | 121 | 0.190 |
Why?
| | Neoplasms, Plasma Cell | 1 | 2015 | 7 | 0.190 |
Why?
| | Leukocytosis | 1 | 2015 | 27 | 0.190 |
Why?
| | Lipoma | 1 | 2015 | 10 | 0.180 |
Why?
| | Tenosynovitis | 1 | 2015 | 9 | 0.180 |
Why?
| | Gene Frequency | 1 | 2017 | 507 | 0.180 |
Why?
| | Natalizumab | 2 | 2012 | 40 | 0.180 |
Why?
| | Soft Tissue Neoplasms | 1 | 2015 | 62 | 0.170 |
Why?
| | Pyrazoles | 1 | 2017 | 297 | 0.160 |
Why?
| | Tissue Culture Techniques | 1 | 2013 | 74 | 0.160 |
Why?
| | Genomic Instability | 1 | 2013 | 49 | 0.160 |
Why?
| | Humans | 16 | 2018 | 89065 | 0.150 |
Why?
| | Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 16 | 0.150 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 1 | 2012 | 33 | 0.150 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 100 | 0.140 |
Why?
| | CD3 Complex | 1 | 2012 | 91 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2015 | 170 | 0.140 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 512 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2016 | 596 | 0.140 |
Why?
| | Immunologic Factors | 1 | 2012 | 160 | 0.130 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1209 | 0.130 |
Why?
| | Middle Aged | 5 | 2018 | 23512 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1840 | 0.120 |
Why?
| | Neutrophils | 1 | 2015 | 1090 | 0.120 |
Why?
| | Bone Marrow | 3 | 2017 | 206 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 1880 | 0.110 |
Why?
| | Lymphatic Diseases | 1 | 2008 | 22 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2015 | 1070 | 0.110 |
Why?
| | Neutropenia | 1 | 2008 | 123 | 0.110 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2007 | 52 | 0.110 |
Why?
| | Racemases and Epimerases | 1 | 2006 | 8 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2050 | 0.100 |
Why?
| | Mucins | 1 | 2006 | 59 | 0.090 |
Why?
| | Female | 8 | 2017 | 50643 | 0.090 |
Why?
| | Carcinoma, Renal Cell | 1 | 2007 | 154 | 0.090 |
Why?
| | Prostate-Specific Antigen | 1 | 2006 | 158 | 0.090 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 336 | 0.090 |
Why?
| | Diagnosis, Differential | 2 | 2007 | 1420 | 0.090 |
Why?
| | Male | 7 | 2018 | 50203 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2008 | 275 | 0.090 |
Why?
| | Kidney Neoplasms | 1 | 2007 | 274 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2007 | 479 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 459 | 0.070 |
Why?
| | Adult | 5 | 2016 | 25891 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2006 | 773 | 0.070 |
Why?
| | Temporomandibular Joint | 1 | 2016 | 12 | 0.050 |
Why?
| | Cranial Fossa, Middle | 1 | 2016 | 5 | 0.050 |
Why?
| | Frontal Bone | 1 | 2016 | 13 | 0.050 |
Why?
| | Occipital Bone | 1 | 2016 | 21 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2017 | 260 | 0.050 |
Why?
| | Sphenoid Bone | 1 | 2016 | 19 | 0.050 |
Why?
| | Neoplasm, Residual | 1 | 2016 | 43 | 0.050 |
Why?
| | Temporal Bone | 1 | 2016 | 57 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2016 | 206 | 0.050 |
Why?
| | Administration, Oral | 1 | 2017 | 673 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2015 | 136 | 0.050 |
Why?
| | Recurrence | 1 | 2017 | 807 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2015 | 318 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 316 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2015 | 412 | 0.040 |
Why?
| | Karyotype | 1 | 2013 | 4 | 0.040 |
Why?
| | Chondrogenesis | 1 | 2013 | 39 | 0.040 |
Why?
| | Heterografts | 1 | 2013 | 92 | 0.040 |
Why?
| | Odds Ratio | 1 | 2016 | 972 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2017 | 7773 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2013 | 267 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2013 | 80 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2013 | 291 | 0.040 |
Why?
| | Biopsy | 1 | 2015 | 958 | 0.040 |
Why?
| | Mice, Nude | 1 | 2013 | 686 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2017 | 702 | 0.030 |
Why?
| | Prognosis | 1 | 2017 | 2677 | 0.030 |
Why?
| | Disease Progression | 1 | 2017 | 1920 | 0.030 |
Why?
| | Aged | 2 | 2017 | 16052 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4108 | 0.030 |
Why?
| | Genetic Variation | 1 | 2013 | 811 | 0.030 |
Why?
| | Multiple Sclerosis | 1 | 2012 | 306 | 0.030 |
Why?
| | Leukocyte Elastase | 1 | 2008 | 80 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2012 | 497 | 0.030 |
Why?
| | Cytokines | 1 | 2015 | 1736 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2454 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 5511 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6427 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1591 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2048 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2008 | 1136 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2017 | 7270 | 0.020 |
Why?
| | Adolescent | 1 | 2017 | 14618 | 0.020 |
Why?
| | Brain | 1 | 2012 | 2408 | 0.020 |
Why?
| | Young Adult | 1 | 2013 | 7703 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2008 | 4258 | 0.010 |
Why?
| | Mice | 1 | 2013 | 13679 | 0.010 |
Why?
| | Infant | 1 | 2008 | 6480 | 0.010 |
Why?
| | Child | 1 | 2008 | 12781 | 0.010 |
Why?
| | Animals | 1 | 2013 | 32175 | 0.010 |
Why?
|
|
Schowinsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|